Firsekibart schedules for preventing gout attacks
Part of Bones, joints & muscles, Kidney & urinary clinical trials.
This trial tests whether taking firsekibart (a gout prevention injection) on a regular schedule works better than taking it only when needed. You would be eligible if you've already completed 24 weeks of firsekibart without gout flares and are willing to continue gout-lowering medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 years old
- Diagnosed with gout using standard criteria
- Completed 24 weeks of firsekibart injections with no gout attacks during that time
- Had at least 2 gout attacks in the year before starting firsekibart
- Willing to take urate-lowering therapy (medication to reduce uric acid) as directed
- Not pregnant, breastfeeding, or planning pregnancy without contraception
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This trial tests a new drug called firsekibart against an existing drug, anakinra, for people with active adult-onset Still's disease. It aims to see if firsekibart is more effective in controlling symptoms like fever, joint pain, and rash.
This study tests whether a potassium citrate tablet can help people with gout lower uric acid and prevent flares. It is for adults on stable gout medication who are not having a current flare.
This study tests whether a new drug called firsekibart can help prevent gout from coming back. If you've had multiple gout attacks in the past year and are currently having one, this trial may help you and advance gout treatment.
Hear when a new Gout Flares trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.